Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation.

M Sykes1, Z Bukhari, D H Sachs

  • 1Transplantation Biology Section, National Cancer Institute, Bethesda, MD 20892.

Bone Marrow Transplantation
|September 1, 1989
PubMed
Summary

Allogeneic bone marrow transplantation can eliminate leukemia without causing graft-versus-host disease when combined with T cell-depleted syngeneic marrow, offering a safer approach for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.

Transplantation·2001
Same author

Xenotransplantation.

Advances in immunology·2001
Same author

Enhanced CD4 reconstitution by grafting neonatal porcine tissue in alternative locations is associated with donor-specific tolerance and suppression of preexisting xenoreactive T cells.

Transplantation·2001
Same author

Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons.

Transplantation·2001
Same author

Persistence of dominant T cell clones in accepted solid organ transplants.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Neuropathy in miniature swine after administration of the mutant diphtheria toxin-based immunotoxin, pCD3-CRM9.

Transplantation·2001

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • T cell-depleted (TCD) syngeneic marrow protects against graft-versus-host disease (GVHD) but is eliminated by non-TCD allogeneic marrow.
  • This suggests allogeneic marrow might eliminate host leukemia when TCD syngeneic marrow is co-administered for GVHD protection.

Purpose of the Study:

  • Establish a new mouse model to evaluate the anti-leukemic potential of allogeneic marrow combined with TCD syngeneic marrow.
  • Assess the safety and efficacy of this combined approach in preventing GVHD while eradicating leukemia.

Main Methods:

  • Lethally irradiated mice received EL4 leukemia cells along with syngeneic marrow or a mixture of TCD syngeneic plus non-TCD allogeneic marrow.
  • Evaluated mortality, GVHD incidence, and chimerism post-transplantation.

Related Experiment Videos

Main Results:

  • Non-TCD allogeneic marrow, unlike syngeneic marrow, delayed or prevented mortality from EL4 leukemia without causing apparent GVHD.
  • Co-administration of TCD syngeneic marrow did not attenuate the anti-leukemic effect of allogeneic marrow, leading to complete allogeneic chimerism.
  • Similar anti-leukemic effects were observed in haploidentical combinations and against established tumors.

Conclusions:

  • Combined allogeneic and TCD syngeneic marrow transplantation demonstrates anti-leukemic efficacy without GVHD.
  • This approach may enhance the safety of clinical bone marrow transplantation across HLA disparities.
  • It allows leveraging the anti-leukemic and engraftment-promoting effects of T cells in allogeneic marrow inocula.